Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism

Yun Dai, Terry H. Landowski, Steven T. Rosen, Paul Dent, Steven Grant

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds